Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats
Authors
Keywords
Schizophrenia, THC, Cannabinoid CB1 receptor, Dopamine D2 receptor, Cannabidiol, DNA methylation, Epigenetics
Journal
PHARMACOLOGICAL RESEARCH
Volume -, Issue -, Pages 105357
Publisher
Elsevier BV
Online
2020-12-05
DOI
10.1016/j.phrs.2020.105357
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors
- (2020) Naielly Rodrigues da Silva et al. PHARMACOLOGICAL RESEARCH
- Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors
- (2020) Gemma Navarro et al. PHARMACOLOGICAL RESEARCH
- Endocannabinoid System Components as Potential Biomarkers in Psychiatry
- (2020) Francisco Navarrete et al. Frontiers in Psychiatry
- Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment
- (2020) Tibor Stark et al. BIOCHEMICAL PHARMACOLOGY
- Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue
- (2020) Jan Kucera et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Sex differences in schizophrenia, bipolar disorder and PTSD: Are gonadal hormones the link?
- (2019) Andrea Gogos et al. BRITISH JOURNAL OF PHARMACOLOGY
- Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders
- (2019) Daniel Friedman et al. LANCET NEUROLOGY
- Gender differences in the effects of cannabidiol on ethanol binge drinking in mice
- (2019) Adrián Viudez-Martínez et al. ADDICTION BIOLOGY
- Role of endocannabinoid system in dopamine signalling within the reward circuits affected by chronic pain
- (2019) Jakub Mlost et al. PHARMACOLOGICAL RESEARCH
- Recent advances in the neurobiology of posttraumatic stress disorder: A review of possible mechanisms underlying an effective pharmacotherapy
- (2019) Natalia Malikowska-Racia et al. PHARMACOLOGICAL RESEARCH
- Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
- (2019) Davide Amato et al. Frontiers in Psychiatry
- Systematic review: Impact of resveratrol exposure during pregnancy on maternal and fetal outcomes in animal models of human pregnancy complications—Are we ready for the clinic?
- (2019) Jack R.T. Darby et al. PHARMACOLOGICAL RESEARCH
- Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats
- (2019) Eva Drazanova et al. Scientific Reports
- Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders
- (2019) Maria Rosaria Domenici et al. PHARMACOLOGICAL RESEARCH
- Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone
- (2019) Roberto Frau et al. NATURE NEUROSCIENCE
- Consequences of Perinatal Cannabis Exposure
- (2019) Andrew F. Scheyer et al. TRENDS IN NEUROSCIENCES
- Endocannabinoid system, Stress and HPA axis
- (2018) Vincenzo Micale et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Long-lasting effects of early-life intervention in mice on adulthood behaviour, GABA A receptor subunit expression and synaptic clustering
- (2018) Kelly J. Skilbeck et al. PHARMACOLOGICAL RESEARCH
- Epigenetic modulation by small molecule compounds for neurodegenerative disorders
- (2018) Akash Kumar Singh et al. PHARMACOLOGICAL RESEARCH
- Cannabis use during pregnancy: Pharmacokinetics and effects on child development
- (2018) Kimberly S. Grant et al. PHARMACOLOGY & THERAPEUTICS
- Preventing Childhood and Lifelong Disability: Maternal Dietary Supplementation for Perinatal Brain Injury
- (2018) Oriana E.F. Shaw et al. PHARMACOLOGICAL RESEARCH
- Neuronal mechanisms mediating pathological reward-related behaviors: A focus on silent synapses in the nucleus accumbens
- (2018) Dillon S. McDevitt et al. PHARMACOLOGICAL RESEARCH
- Special issue: “Perinatal therapeutics: Novel approaches to target adverse pregnancy outcomes and shape offspring health”
- (2018) Stephane L. Bourque et al. PHARMACOLOGICAL RESEARCH
- Synaptic structural protein dysfunction leads to altered excitation inhibition ratios in models of autism spectrum disorder
- (2018) Brian W. Howell et al. PHARMACOLOGICAL RESEARCH
- A fresh look at cortical dopamine D2 receptor expressing neurons
- (2018) Clémentine Quintana et al. PHARMACOLOGICAL RESEARCH
- The effect of polypharmacy on prefrontal cortex activation during single and dual task walking in community dwelling older adults
- (2018) Claudene J. George et al. PHARMACOLOGICAL RESEARCH
- The critical role of microRNAs in stress response: therapeutic prospect and limitation
- (2018) Jie Du et al. PHARMACOLOGICAL RESEARCH
- Behavioral and Pharmacokinetic Profile of Indole-Derived Synthetic Cannabinoids JWH-073 and JWH-210 as Compared to the Phytocannabinoid Δ9-THC in Rats
- (2018) Libor Uttl et al. Frontiers in Neuroscience
- Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia
- (2018) Tibor Stark et al. NEUROPHARMACOLOGY
- HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals
- (2017) Josef Večeřa et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus
- (2017) Vincenzo Micale et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments
- (2017) Justine Renard et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia
- (2017) Jana Ruda-Kucerova et al. NEUROTOXICITY RESEARCH
- Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology
- (2017) Roger Hudson et al. PSYCHOPHARMACOLOGY
- A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia
- (2017) Claudio D'Addario et al. SCHIZOPHRENIA RESEARCH
- At the Tip of an Iceberg: Prenatal Marijuana and Its Possible Relation to Neuropsychiatric Outcome in the Offspring
- (2016) Alán Alpár et al. BIOLOGICAL PSYCHIATRY
- Altering the course of schizophrenia: progress and perspectives
- (2016) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats
- (2016) Jana Ruda-Kucerova et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid
- (2016) M Servadio et al. Translational Psychiatry
- Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose
- (2016) P Seeman Translational Psychiatry
- DNA methylation differences in monozygotic twin pairs discordant for schizophrenia identifies psychosis related genes and networks
- (2015) Christina A Castellani et al. BMC Medical Genomics
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes
- (2015) Alejandro Higuera-Matas et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice
- (2014) Ana Luisa B. Terzian et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Neurodevelopment, GABA System Dysfunction and Schizophrenia
- (2014) Martin J Schmidt et al. NEUROPSYCHOPHARMACOLOGY
- Identifying Gene-Environment Interactions in Schizophrenia: Contemporary Challenges for Integrated, Large-scale Investigations
- (2014) SCHIZOPHRENIA BULLETIN
- Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry
- (2014) Guadalupe Muñoz-Arenas et al. SYNAPSE
- Peripheral Blood Mononuclear Cells as a Laboratory to Study Dementia in the Elderly
- (2014) Beatrice Arosio et al. Biomed Research International
- Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms
- (2014) Petra Amchova et al. Frontiers in Pharmacology
- Leading compounds for the validation of animal models of psychopathology
- (2013) Vincenzo Micale et al. CELL AND TISSUE RESEARCH
- Smoking and Marijuana Use in Pregnancy
- (2013) HAYWOOD L. BROWN et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- Epigenetic mechanisms and endocannabinoid signalling
- (2013) Claudio D'Addario et al. FEBS Journal
- Methylation Patterns in Whole Blood Correlate With Symptoms in Schizophrenia Patients
- (2013) Jingyu Liu et al. SCHIZOPHRENIA BULLETIN
- Endocannabinoid metabolism in the prefrontal cortex in schizophrenia
- (2013) David W. Volk et al. SCHIZOPHRENIA RESEARCH
- Developmental origins of brain disorders: roles for dopamine
- (2013) Kelli M. Money et al. Frontiers in Cellular Neuroscience
- The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats
- (2012) Alessandra Tamburella et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction
- (2012) M Ayalew et al. MOLECULAR PSYCHIATRY
- Comparison of brain and blood gene expression in an animal model of negative symptoms in schizophrenia
- (2012) Fokko J. Bosker et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- CB1 and CB2 Receptor Expression and Promoter Methylation in Patients with Cannabis Dependence
- (2012) Andrea Rotter et al. EUROPEAN ADDICTION RESEARCH
- Maternal Cannabis Use Alters Ventral Striatal Dopamine D2 Gene Regulation in the Offspring
- (2011) Jennifer A. DiNieri et al. BIOLOGICAL PSYCHIATRY
- Neurodevelopmental hypothesis of schizophrenia
- (2011) Michael J. Owen et al. BRITISH JOURNAL OF PSYCHIATRY
- Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment
- (2011) Claudia V. Morris et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors
- (2011) Ana Luisa Terzian et al. Frontiers in Behavioral Neuroscience
- Sexually Dimorphic Effects of Cannabinoid Compounds on Emotion and Cognition
- (2011) Tiziana Rubino et al. Frontiers in Behavioral Neuroscience
- Differential Subcellular Recruitment of Monoacylglycerol Lipase Generates Spatial Specificity of 2-Arachidonoyl Glycerol Signaling during Axonal Pathfinding
- (2010) E. Keimpema et al. JOURNAL OF NEUROSCIENCE
- Antipsychotic Dosing: How Much but also How Often?
- (2010) G. Remington et al. SCHIZOPHRENIA BULLETIN
- Neonatal Behavioral Changes in Rats With Gestational Exposure to Lipopolysaccharide: A Prenatal Infection Model for Developmental Neuropsychiatric Disorders
- (2010) M. Baharnoori et al. SCHIZOPHRENIA BULLETIN
- Cannabis and psychosis/schizophrenia: human studies
- (2009) Deepak Cyril D’Souza et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats
- (2009) Alexandre Seillier et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Ligand-Induced Regulation and Localization of Cannabinoid CB1 and Dopamine D2L Receptor Heterodimers
- (2009) J. A. Przybyla et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
- (2009) O. D. Howes et al. SCHIZOPHRENIA BULLETIN
- Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: A possible role for the endocannabinoid system
- (2008) Ricardo Llorente et al. Developmental Neurobiology
- Cross-fostering effect on postnatal development of rat pups exposed to methamphetamine during gestation and preweaning periods
- (2008) Marie Pometlová et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Looking for the role of cannabinoid receptor heteromers in striatal function
- (2008) Sergi Ferré et al. NEUROPHARMACOLOGY
- Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats
- (2008) Viviana Trezza et al. PSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started